Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer

Abroad (travel likely)Recruiting

Conditions

Gastric Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Ting Deng, MD) · xymcdengting@126.com · 022-23340123-1051

Study leads

Ting Deng, MD
Principal Investigator
Tianjin Medical University Cancer Institute and Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer

Gastric Cancer Adenocarcinoma Metastatic

Abroad (travel likely)RecruitingPHASE2

Beijing, China

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors · Triple Negative Breast Cancer (TNBC) · HR+ Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Denver, United States · Houston, United States

Comparison of Partial Stomach-Partitioning and Conventional Gastrojejunostomy for the Treatment of Gastric Outlet Obstruction in Advanced Gastric Cancer

Gastric Cancer

Abroad (travel likely)Recruiting

Nanning, China

Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer

Gastric Cancer · Chemotherapy-induced Peripheral Neuropathy · Paclitaxel

Abroad (travel likely)Recruiting

Kurashiki, Japan